BRAND_ANALYSIS #BIONTECH HEALTH & PHARMA #16 OF 26 IN HEALTH & PHARMA ALIGNED

BioNTech

· Public · Updated 04 Oct 2026 09:24 UTC
#688 of 1208 overall by tension · #16 of 26 in Health & Pharma
12 Aligned
The Balanced
Analysis

BioNTech's post-vaccine crash is complete: cultural relevance (C=46) and business (B=34) both cratered, sentiment at -0.30 is the scoreboard. When a brand's entire narrative was crisis response, the crisis ending is a death sentence.

IN THE NEWS (92 articles this week)
BioNTech to shutter three sites in Germany as no buyers emerge - Reuters
BioNTech to close 3 sites in Germany after failed buyer search - Fierce Pharma
Germany news: COVID vaccine maker BioNTech to close 3 sites - dw.com
Cultural Score
46 / 100
Business Score
34 / 100
TENSION▁▁▁▁▁▂▁▁▁▃▃▂▂▁
CULTURAL▄▄▄▄▄▅▄▅▄▄▄▄▄▄
BUSINESS▄▄▄▄▄▃▃▄▃▂▂▂▃▃
Loading...
Wikipedia Momentum 15/40
News Presence 31/35
Search InterestRedistributed to other dimensions
Stock Momentum 12/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 3/20
Price$96.90
30d Change-6.7%
Market Cap$24.3B
Profit Margin-63.6%
BioNTech's tension is 12. Culture outpacing commerce. sociologyofcapitalism.com/brand/biontech
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/biontech.html" width="320" height="200" frameborder="0"></iframe>